Arsenic Trioxide Inhibits the Growth of Cisplatin-Resistant Cervical Cancer through the NPM1–p53 Signaling Axis
- DOI
- 10.21203/rs.3.rs-11254700/v1
- Published
- 2026-10-18
- Container
- Not recorded
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21203/rs.3.rs-11254700/v1,
title = {Arsenic Trioxide Inhibits the Growth of Cisplatin-Resistant Cervical Cancer through the NPM1–p53 Signaling Axis},
author = {Sijin L and Chan Y and Haixia X and Linlin X and An L and Feimei L and Ying Z and Songping L.},
year = {2026},
doi = {10.21203/rs.3.rs-11254700/v1},
url = {https://doi.org/10.21203/rs.3.rs-11254700/v1}
}RIS
TY - JOUR TI - Arsenic Trioxide Inhibits the Growth of Cisplatin-Resistant Cervical Cancer through the NPM1–p53 Signaling Axis AU - Sijin L AU - Chan Y AU - Haixia X AU - Linlin X AU - An L AU - Feimei L AU - Ying Z AU - Songping L. PY - 2026 DO - 10.21203/rs.3.rs-11254700/v1 UR - https://doi.org/10.21203/rs.3.rs-11254700/v1 ER -
APA
L, S., Y, C., X, H., X, L., L, A., L, F., Z, Y., & L., S. (2026). Arsenic Trioxide Inhibits the Growth of Cisplatin-Resistant Cervical Cancer through the NPM1–p53 Signaling Axis. https://doi.org/10.21203/rs.3.rs-11254700/v1
Source records
- europe-pmc · retrieved 2026-11-10T15:06:25.419Z